Applied Capital LLC FL Reduces Position in The Procter & Gamble Company (NYSE:PG)

Applied Capital LLC FL lowered its stake in The Procter & Gamble Company (NYSE:PG) by 3.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,353 shares of the company’s stock after selling 403 shares during the quarter. Procter & Gamble makes up 1.8% of Applied Capital LLC FL’s investment portfolio, making the stock its 23rd largest position. Applied Capital LLC FL’s holdings in Procter & Gamble were worth $1,837,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Bleakley Financial Group LLC raised its position in Procter & Gamble by 1.5% in the 1st quarter. Bleakley Financial Group LLC now owns 63,557 shares of the company’s stock worth $9,450,000 after purchasing an additional 938 shares during the period. Crewe Advisors LLC grew its stake in Procter & Gamble by 5.9% in the first quarter. Crewe Advisors LLC now owns 9,213 shares of the company’s stock worth $1,370,000 after purchasing an additional 514 shares during the period. Harbour Investment Management LLC grew its position in shares of Procter & Gamble by 3.6% in the 1st quarter. Harbour Investment Management LLC now owns 17,887 shares of the company’s stock worth $2,660,000 after buying an additional 620 shares during the period. Doliver Advisors LP grew its stake in shares of Procter & Gamble by 10.9% in the 1st quarter. Doliver Advisors LP now owns 9,454 shares of the company’s stock worth $1,406,000 after buying an additional 931 shares during the last quarter. Finally, Argent Trust Co increased its holdings in shares of Procter & Gamble by 3.9% during the first quarter. Argent Trust Co now owns 125,092 shares of the company’s stock valued at $18,600,000 after acquiring an additional 4,676 shares in the last quarter. 63.43% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Down 0.3 %

Shares of PG traded down $0.42 during mid-day trading on Wednesday, hitting $152.02. 1,249,097 shares of the company traded hands, compared to its average volume of 6,238,814. The company has a quick ratio of 0.44, a current ratio of 0.63 and a debt-to-equity ratio of 0.53. The business has a 50 day moving average of $153.00 and a 200 day moving average of $149.58. The Procter & Gamble Company has a 1-year low of $122.18 and a 1-year high of $158.38. The company has a market capitalization of $358.36 billion, a PE ratio of 25.84, a price-to-earnings-growth ratio of 3.84 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, July 28th. The company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.32 by $0.05. The company had revenue of $20.60 billion during the quarter, compared to analysts’ expectations of $20.01 billion. Procter & Gamble had a net margin of 17.87% and a return on equity of 32.88%. The firm’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.21 earnings per share. Equities research analysts anticipate that The Procter & Gamble Company will post 6.39 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Friday, July 21st were paid a $0.9407 dividend. This represents a $3.76 dividend on an annualized basis and a yield of 2.48%. The ex-dividend date of this dividend was Thursday, July 20th. Procter & Gamble’s dividend payout ratio (DPR) is 63.73%.

Insider Buying and Selling

In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 33,022 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $156.26, for a total transaction of $5,160,017.72. Following the sale, the chief accounting officer now directly owns 888 shares in the company, valued at $138,758.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CAO Matthew W. Janzaruk sold 33,022 shares of the stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $156.26, for a total value of $5,160,017.72. Following the transaction, the chief accounting officer now directly owns 888 shares of the company’s stock, valued at approximately $138,758.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Balaji Purushothaman sold 12,629 shares of the firm’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $157.19, for a total transaction of $1,985,152.51. Following the transaction, the insider now directly owns 13,051 shares in the company, valued at $2,051,486.69. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 106,607 shares of company stock worth $16,523,793. 0.17% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on PG shares. JPMorgan Chase & Co. raised their price target on shares of Procter & Gamble from $164.00 to $172.00 in a report on Friday, July 28th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Procter & Gamble from $170.00 to $173.00 and gave the company a “buy” rating in a report on Monday, July 31st. Wells Fargo & Company boosted their price target on Procter & Gamble from $165.00 to $170.00 and gave the stock an “overweight” rating in a report on Monday, July 31st. Royal Bank of Canada boosted their target price on shares of Procter & Gamble from $165.00 to $167.00 and gave the stock a “sector perform” rating in a report on Monday, July 31st. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $174.00 price target on shares of Procter & Gamble in a research note on Tuesday, August 1st. Six equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $164.82.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.